Tuesday, April 25, 2017 1:53:18 PM
You say the company will be cash flow positive, wouldn't that statement be a bit premature as well? Right?
The stock reflects what the general public feels about IPCI right now.
Can IPCI secure a Rexista deal to pave the way for advancing the pipeline? That may also generate enough funding to go into the next year or two at the very least.
I kept myself from buying a lot more shares just yet because I too felt the same way. Management can say what they want, whether or not they deliver is what really matters.
I am not looking just for break even. As I said, biotech needs to be constantly advancing their pipeline. They might be break even now, but we know competition will eventually drive profit lower as seen with Facolin. You see why people aren't willing to hold just yet? Simply because there is nothing that secures a big upside for the future.
As IPCI gets more approval, and increase revenue, it will make a lot more investors feel at ease buying and holding. A Rexista and PODRAS deal would really be the key to the future. But again, using your word, it's a bit premature wouldn't you say?
I am not saying IPCI will fail or anything, I'm just pointing out what general public feels about IPCI right now. On watch but won't commit just yet.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM